Case Reports
doi: 10.1111/j.1365-2133.2006.07672.x.
Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene
- PMID: 17300259
- DOI: 10.1111/j.1365-2133.2006.07672.x
Item in Clipboard
Case Reports
Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene
Br J Dermatol.
2007 Mar.
No abstract available
Similar articles
-
Bexarotene monotherapy for patients with advanced stage mycosis fungoides.Dermatol Clin. 2008 Jan;26 Suppl 1:25-6. Dermatol Clin. 2008. PMID: 18405183 No abstract available.
-
Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.Dermatol Clin. 2008 Jan;26 Suppl 1:51-2. Dermatol Clin. 2008. PMID: 18405188 No abstract available.
-
Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.Dermatol Clin. 2008 Jan;26 Suppl 1:33-5. Dermatol Clin. 2008. PMID: 18405185 No abstract available.
-
Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.Br J Dermatol. 2005 Jun;152(6):1379-81. doi: 10.1111/j.1365-2133.2005.06616.x. Br J Dermatol. 2005. PMID: 15949024 Review. No abstract available.
-
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.Am J Hematol. 2008 Sep;83(9):744-6. doi: 10.1002/ajh.21231. Am J Hematol. 2008. PMID: 18615708 Review.
Cited by
-
Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides.Acta Derm Venereol. 2017 Mar 10;97(3):373-374. doi: 10.2340/00015555-2551. Acta Derm Venereol. 2017. PMID: 27868149 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
